- Risk Trade Is Back On
- This Week's Biggest Story: The Dollar
- Corporate Issuance Continues at Torrid Pace
- The Bernanke Dollar Bounce & Gross Says Forget About Rate Hike
- Colgate Really Sparkles After Hours
- Light Volume Has Traders Complaining
- Gold Shatters Another Record
- Have Retailers Reached Their Limits?
- The Retail Mind Game
- The Gold Rush Is On
TRADER TALK RSS FEED
MOST SHARED
- The 'Real' Jobless Rate: 17.5% Of Workers Are Unemployed
- US Home Prices Up 5th Month, 2nd Straight Quarter
- GM's Agreement to Sell Saab To Swedish Firm Falls Apart
- FDIC Fund Falls into The Red, Bair Urges Lending
- Buyers Look For Bargains At Luxury Condo Auction
- Weak Dollar Is Golden for Mining Companies
- Revised GDP Reading Puts Growth at 2.8%; Inflation Tame
- 10 Holiday Cocktail Recipes from Top Mixologists
- Behind The Scenes With Warren Buffett
- CA "More Profitable" After Saving Energy: CEO
- My 2010 Home Price Outlook: UBS Analyst
- Why Are Options Piling into Dollar Tree?
- Novartis 'Cells' Its Flu Vaccine Technology
- Silicon Valley and Hollywood Now Fast Friends
- Markets Can Rise 5-10% in the Near-Term: Strategist
- Busch: The Debt-Interest Rate Paradox
- The Lloyd's Prayer, Leggo My Eggo, Plate Hate & Your Emails
- Buy These 'Competitively Positioned' Stocks: Portfolio Manager
- Behind The Scenes With Warren Buffett
- Turkey Day 101: How Well Do You Know Your Bird?
- $42 Billion US Bond Auction Receives Strong Demand
- GM's Agreement to Sell Saab Unit Falls Apart
- Consumer Confidence Improves but Still Shaky
- US Home Prices Up 5th Month, 2nd Straight Quarter
- FDIC Fund Falls into The Red, Bair Urges Lending
- Holiday Guide to This Season's Smartphones
- Six Ways to Boost Your Income in a Big Way
- Buyers Look for Bargains at Luxury Condo Auction
More Videos
Trader Talk
Text Size 
The swine flu epidemic remains a wild card, as no one is quite certain how far the epidemic will spread.
Let the fighting over the stress test begin. We knew there would be a one-week period when banks would know the results of the stress test and be able to dispute them, and we are in the middle of that period.
This is also the perfect moment to have leaks about those results, and indeed the WSJ reported that the Bank of America and Citigroup may have to raise more capital. Is anyone seriously surprised that either need to raise capital?
Deutsche Bank, in initiating coverage of the banks this morning, stressed the fundamentals: that credit continues to deteriorate, but that government actions should prevent stocks from hitting new lows.
The likely outcome of all this, DB says: banks stocks will "trade in a wide range (with current prices near the top end of this range) until we receive more clarity on credit."
Elsewhere:
1) Of the many earnings reports, building supplier Masco and steel giant U.S. Steel stand out. U.S. Steel, down 8 percent pre-open, reported earnings well below expectations (loss of $3.78 vs. expectations of a loss of $1.62, with topline of $2.75 billion also below expectations of $3.19 billlion). Dividend was cut to $0.05 from $0.30.
The problem was order rates below expectations and further downward pressure on steel prices.
Like Alcoa, they have initiated a pre-emptive capital raise, raising equity and convertible debt to pay down its term loans with strict covenants. The equity raise is about $800 million, about a quarter of U.S. Steel's current market capitalization.
No real guidance, other than the expectation of an earnings losss.
Masco (think KraftMaid cabinets, Delta faucets, Behr paints) reported operating earnings roughly in line with expectations. However, it appeared that the cabinet division underperformed, while paints did better than expected. This makes some sense: big-ticket items like cabinets suffer, but lower-ticket, high-impact items like paint do better. 2009 guidance was lowered slightly. Much of this depends on housing starts, which they are putting around 550,000.
2) Shares of Dow component Pfizer are up 1 percent after its Q1 earnings beat estimates. Revenues for the pharmaceutical giant fell 8.3 percent, as a 13 percent drop in sales of cholesterol drug Lipitor and the impact of a stronger dollar hurt top line results. Pfizer reaffirms full-year guidance (excluding Wyeth merger costs).
3) Despite rising costs, Coventry Health Care's Q1 earnings beat analyst expectations by 5 cents. The health care provider also reported an 11 percent rise in membership and reaffirmed its outlook for the year.
4) Office supplies retailer Office Depot is trading up 6 percent pre-open after posting Q1 EPS of 10-cents - well above the 10-cent loss expected by the street. Sales continued to struggle though, falling 19 percent in the quarter as many consumers put off purchases of higher-priced furniture and computers.
5) Rockwell Collins' Q2 earnings beat estimates, but the aerospace company cut its outlook for the second time. Hurt by slumping demand for its commercial airplane components, the company now expects 2009 earnings per share of $3.70-$3.90, down from $4.10-$4.30.
_____________________________
_____________________________
Questions? Comments?
POPULAR TRADER TALK POSTS
- Risk Trade Is Back On
- This Week's Biggest Story: The Dollar
- Corporate Issuance Continues at Torrid Pace
- The Bernanke Dollar Bounce & Gross Says Forget About Rate Hike
- Colgate Really Sparkles After Hours
- Light Volume Has Traders Complaining
- Gold Shatters Another Record
- Have Retailers Reached Their Limits?
- The Retail Mind Game
- The Gold Rush Is On
Data is a real-time snapshot *Data is delayed at least 15 minutes